Skip to content
BIOGENA Junior Balance Formula + CoQ10
Children's micronutrient complexes · capsules

BIOGENA Junior Balance Formula + CoQ10

120 capsules · 1–2 capsules per day

List price33.90 €120 capsules
Price/day0.28–0.57 €
Supply60–120 days
25 € discount
Code AD1131373
from 75 € order value
View product Advertising/Affiliate link
Current product/batch-specific notice: Contains soy via the ubiquinol ingredient. Do not exceed the recommended age-dependent daily dose. (checked 16 Sep 2026)

Product description

Multi-ingredient formula for children with magnesium, zinc, vitamin B6, vitamin B12, taurine, ubiquinol, manganese and grape seed extract. Dosage depends on age.

Checked: 16 Sep 2026• Ingredients list complete• Lab report available• without MCC• without silicon dioxide
Editorial assessment

Assessment by Oliver Fröhner

Micronutrient expert & Food Coach

Product character

The formula focuses on combined micronutrient intake with magnesium and zinc plus B vitamins, complemented by taurine and ubiquinol. The structured 2-capsule reference dose corresponds to the manufacturer's recommendation from age 11.

Formula & transparency

  • Ingredients list fully checked
  • Without microcrystalline cellulose according to the fully reviewed ingredient list
  • Without silicon dioxide according to the fully reviewed ingredient list
  • Product data reviewed within the freshness period

Points to consider

  • A current product- or batch-specific notice is available.

Data basis

  • Lab report available but not marked as reviewed
  • HPMC/hydroxypropyl methylcellulose is declared.

Summary by Oliver Fröhner

Multi-ingredient formula for children with magnesium, zinc, vitamin B6, vitamin B12, taurine, ubiquinol, manganese and grape seed extract. Dosage depends on age.

Manufacturer information and Oliver Fröhner’s editorial assessment are presented separately. Data checked: 16 Sep 2026.

Active ingredients & NRV

Active ingredients

Grape Seed Extract — 20 mg · per Daily dose
Taurine — 50 mg · per Daily dose
Zinc Zinc Bisglycinate 10 mg · per Daily dose100 % NRV
Magnesium Magnesium Citrate 200 mg · per Daily dose53 % NRV
Vitamin B6 Pyridoxal 5-Phosphate 4.2 mg · per Daily dose300 % NRV
Coenzyme Q10 Ubiquinol 7 mg · per Daily dose
Vitamin B12 Methylcobalamin 7.5 µg · per Daily dose300 % NRV
Manganese Manganese Gluconate 2 mg · per Daily dose100 % NRV
Ingredients & additives

BIOGENA Viersalz®-Komplex (Magnesiumcitrat, Magnesiumoxid, Magnesiumgluconat, Magnesiumcarbonat), Hydroxypropylmethylcellulose (Kapselhülle), Taurin, Zinkbisglycinat, Füllstoff: Cellulosepulver; Ubiquinol (enthält Soja), Traubenkern-Extrakt, Mangangluconat, Pyridoxal-5'-phosphat, Vitamin B12 (Methylcobalamin, Hydroxocobalamin, 5‘-Desoxyadenosylcobalamin).

without MCC without SiO₂
Directions & package

Children aged 4–10 years: 1 capsule daily. Children aged 11 years and older: 2 capsules daily with plenty of liquid.

120 capsules · 60–120 days

Quality, lab & sources

Lab status: Lab report available

Product data checked on 16 Sep 2026.

Notes

Contains soy via the ubiquinol ingredient. Do not exceed the recommended age-dependent daily dose.

Nutrient knowledge & reference values

Nutrient knowledge & reference values

General nutrient information for interpreting the product dosage. Signs of insufficient or excessive intake are non-specific and do not replace a diagnosis.

Zinc

Zinc is an essential trace element. The assessment considers the EU NRV, total intake, product dose and interactions—particularly with copper and medicines—separately.

NRV 10 mg European Union · 2011 Product daily dose: 100 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
UL 25 mg EFSA / SCF · 2002 / EFSA Summary 2024 Safety limit for long-term intake; not a target value. Source →
UL 40 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 25 % of the UL; other intake sources are not included. US UL for zinc from all sources. Safety limit, not a target value. Source →

Functions

EU-authorised health-claim functions include, among other things: zinc contributes to the normal function of the immune system, normal cognitive function, normal DNA synthesis, normal fertility and reproduction, and normal acid-base and carbohydrate metabolism. Zinc contributes to the maintenance of normal bones, hair, nails, skin and vision, protects cells from oxidative stress and has a role in the process of cell division.

Possible signs of insufficient intake

Zinc deficiency can be associated, among other things, with loss of appetite, impaired taste and smell, delayed wound healing, hair loss, growth impairment and increased susceptibility to infections. These symptoms are nonspecific and do not allow self-diagnosis.

Points to consider at high intake

Excessive zinc intake can cause nausea, vomiting, headaches and gastrointestinal symptoms. Chronically high amounts can inhibit copper absorption and thereby promote copper deficiency. The European EFSA/SCF UL for adults is 25 mg of zinc per day from total intake.

Special considerations

An increased risk of inadequate zinc intake exists, among other situations, with certain gastrointestinal diseases or after bariatric surgery, with strongly plant-based diets with low zinc bioavailability, during pregnancy and breastfeeding, and with chronically high alcohol consumption.

Interactions / caution

Zinc can reduce the absorption of quinolone and tetracycline antibiotics as well as penicillamine; dosing intervals should be observed. Thiazide diuretics can increase zinc excretion. Long-term high zinc intake can reduce copper absorption.

Knowledge reviewed on 23 Sep 2026

Magnesium

Magnesium is an essential mineral involved in numerous enzymatic reactions. For product assessment, the manufacturer’s dosage, active-ingredient forms and reference values are considered separately.

NRV 375 mg European Union · 2011 Product daily dose: 53 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
UL 250 mg EFSA / SCF · 2001 / EFSA Summary 2024 Product daily dose: 80 % of the UL; other intake sources are not included. UL for readily dissociable magnesium salts/magnesium oxide from food supplements or other added sources; naturally occurring magnesium from foods is not covered in the same way. Source →
UL 350 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 57 % of the UL; other intake sources are not included. The US UL covers magnesium from dietary supplements and medicines, not magnesium naturally present in foods and beverages. Safety limit, not a target value. Source →

Functions

Magnesium contributes, among other things, to normal muscle and nerve function and to normal energy-yielding metabolic processes. It is also involved in processes related to protein, bone and DNA.

Possible signs of insufficient intake

Insufficient magnesium intake can present with nonspecific symptoms; possible indications may include neuromuscular complaints. Individual symptoms do not establish a diagnosis and should not be assessed in isolation.

Points to consider at high intake

High amounts from supplements can mainly cause gastrointestinal symptoms such as diarrhoea, nausea and abdominal cramps. With severely impaired kidney function, the risk of magnesium accumulation increases; high doses should then be medically assessed.

Special considerations

With impaired kidney function, magnesium excretion is reduced. Product dose, magnesium form, tolerance and total intake should therefore be considered separately.

Interactions / caution

Magnesium can affect the absorption of certain medicines, including some antibiotics and bisphosphonates. Timing intervals and individual medication should be reviewed with regular use.

Knowledge reviewed on 23 Sep 2026

Vitamin B6

UL 12 mg EFSA · 2023 Product daily dose: 35 % of the UL; other intake sources are not included. EFSA UL 12 mg/day for adults; includes total intake from foods and supplements and all vitamin B6 vitamers. Safety limit, not a target value. Source →
UL 100 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 4 % of the UL; other intake sources are not included. US UL 100 mg/day for adults from food and supplement sources. Considerably higher than the EFSA UL newly derived in 2023; note the different derivation methods. Source →

Manganese

Manganese is an essential trace element and a cofactor for various enzymes. For safety assessment, it is important that EFSA could not derive a UL and instead established a Safe Level for total intake.

NRV 2 mg European Union · 2011 Product daily dose: 100 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
Safe Level 8 mg EFSA · 2023 Safe Level derived by EFSA; methodologically not identical to a conventional UL. Not a target value. Source →
UL 11 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 18 % of the UL; other intake sources are not included. US UL for manganese from all sources. Methodologically not equivalent to the EFSA Safe Level. Source →

Functions

EU-authorised health-claim functions: manganese contributes to normal energy-yielding metabolism, the maintenance of normal bones, normal formation of connective tissue and the protection of cells from oxidative stress.

Possible signs of insufficient intake

Manganese deficiency is very rare in humans; typical deficiency symptoms are not clearly established. Limited data have described, among other things, changes in bone metabolism, growth, skin and carbohydrate metabolism. These findings are not suitable for self-diagnosis.

Points to consider at high intake

Excessive manganese exposure can cause neurological damage. In 2023, EFSA was unable to establish a UL and instead uses a Safe Level of 8 mg/day for adults from total intake from all dietary sources. Exceeding the Safe Level does not automatically mean a health risk and must not be interpreted like a UL.

Special considerations

No clearly defined general risk groups for inadequate intake are known. Iron deficiency can increase manganese absorption. In chronic liver disease, biliary excretion may be reduced, which can increase sensitivity to excessive manganese exposure. Occupational inhalation exposure must be distinguished from oral dietary intake.

Interactions / caution

No clinically relevant drug interactions are generally established for manganese. In liver disease and with unusually high total intake, particular caution is warranted because of manganese homeostasis.

Knowledge reviewed on 23 Sep 2026
Science & studies

Scientific assessment

Studies, meta-analyses and randomized controlled trials on the active ingredient – explained clearly and linked to sources.

Discount code AD1131373
View product Advertising/Affiliate link

The information is provided for factual classification of product and nutrient data. It does not replace medical diagnosis or individual treatment advice.

Click to access the login or register cheese
Moleqlar experiences

As a scientific co-operation partner of Moleqlar, we have the opportunity to provide you with a discount code for your purchase at Moleqlar. As a micronutrient expert, I am happy to assist you with any questions you may have about Moleqlar products.

10% discount code for moleqlar